[324 Pages Report] The global catheter-directed thrombolysis market is valued at US$ 454.8 million in 2023. The market is likely to grow at a CAGR of 5.9% and is anticipated to be valued at US$ 808 million by 2033.
The demand for catheter-directed thrombolysis is anticipated to increase as the treatment makes use of processes that remove the clot be it based on thrombosis or embolization, the low time duration of treatment, and many other factors. This process is one of the most important preferred methods to treat stroke and related health issues.
| Report Attributes | Details |
|---|---|
| Catheter-Directed Thrombolysis Market Value (2023) | US$ 454.8 million |
| Catheter-Directed Thrombolysis Market Anticipated Value (2033) | US$ 808 million |
| Catheter-Directed Thrombolysis Market Projected Growth Rate (2023 to 2033) | 5.9% |
Even if we compare the historical CAGR with the anticipated CAGR of the forecast period, there is a positive indication for the market. The historical CAGR of the catheter-directed thrombolysis industry from 2018 to 2022 was 4.9%, while the anticipated CAGR is 5.9%. The good thing is that the market is progressing because of the number of benefits catheter-directed thrombolytic therapy offers.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The seamlessness that this process offers is almost unmatchable. The entire process is done under the purview of X-ray imaging to get the correct site of the clot. Moreover, the technique is used for several treatments, which include thrombosis in the vascular bed, deep vein thrombosis, and thrombosis of dialysis fistulate. This is expected to increase the adoption of catheter-directed thrombolysis and makes the entire process an essential form of stroke medication.
Additionally, on comparing with the traditional heart surgery process, the process is extremely safe, and the duration for which the patient is admitted to the hospital is less. Besides that, based on the stats provided by WHO, it was found that around 17.9 million people died from heart disease in 2019, accounting for 32% of global deaths. This is something that has captured the attention of investors in the catheter-directed thrombolysis industry, as these are mainly used for treating heart diseases.
Furthermore, the availability of emergency medical services and favorable health insurance coverage will also fuel the catheter-directed thrombolysis industry. All these are anticipated to have a positive impact on the catheter-directed thrombolysis market trends and forecasts. However, the application of an IV line to administer anesthesia might lead to certain injuries to the skin. This can be a cause of concern for the catheter-directed thrombolysis industry.
The amazing ability to keep real-time track of the movements inside the body part has been made possible because of fluoroscopy. The application of fluoroscopy has been perceived as a life-saving surgical treatment. Apart from showing the real-time view, this method also helps medical practitioners to place the catheters inside the body with precision.
Moreover, fluoroscopy is used in a wide variety of examinations like Barium x-rays, placement of stents, and orthopedic surgery to carry out a variety of treatments which include viewing the gastrointestinal tract, visualizing blood vessels, guiding joint replacements, etc. Thus, from the above, it can be inferred that the usage of fluoroscopy is likely to increase the scope of the catheter-directed thrombolysis industry.
Principal Consultant
| Attributes | Details |
|---|---|
| Replacing X-rays with Ultrasounds | Continuous exposure to X-rays can lead to health complications. Instead of this, the manufacturers can look for ways to replace X-rays with ultrasound, as these can be applied to any kind of patient, even pregnant women. Moreover, there are no side effects associated with the usage of ultrasounds, and the image quality provided by the usage of ultrasounds is also good. Thus, the replacement of X-rays with ultrasound might very well improve the catheter-directed thrombolysis industry outlook. |
| Replacing the IV method with other methods | Instead of applying an invasive technique to administer anesthesia, the administration can be done through other methods, like administering it in the form of a gas, topical liquid, or any injection. The problem associated with intravenous medication is that it can lead to infection and damage the site of veins and may also lead to air embolism. However, replacing the IV line with anesthesia through gas, topical liquid, or injection is expected to avoid any instances of developing a skin infection or any other kind of complication as these are not pierced into the skin, thereby making the process fully non-invasive, except for the case of injection. The application of any one of these methods can be a positive step for the catheter-directed thrombolysis market. |
| Attributes | Details |
|---|---|
| North America | North America is expected to dominate the catheter-directed thrombolysis industry share due to easy access to advanced healthcare facilities. According to Future Market Insights, the North American catheter-directed thrombolysis market has a market share of 53.4% and is expected to grow at a rapid pace during the forecast period. Moreover, the region is meant for rapid technological advances. According to World Health Organization (WHO), approximately 900,000 people were diagnosed with pulmonary embolism and deep vein thrombosis in the USA. in 2015. Among all end users, the hospital segment dominates the market for catheter-directed thrombolysis over the forecast period. The majority of cases of pulmonary embolism and deep vein thrombosis are treated in hospitals. |
| Europe | Europe is considered to be the 2nd largest market for catheter-directed thrombolysis owing to the presence of a robust reimbursement scenario and improved regulatory framework. According to Future Market Insights, the region has a market share of 24.1% and is expected to grow significantly during the forecast period. Catheter-directed thrombolysis (CDT) with assisted mechanical thrombolysis in the region is considered the standard form of treatment. Deep vein thrombosis (DVT) is the third most common cardiovascular pathology after coronary artery disease and stroke in the region. Due to the growing geriatric population and risk factors that include oral contraceptives, the demand for catheter-directed thrombolysis is expected to increase during the forecast period in Europe. |
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Start-ups are developing new products with their unique ideas to solve several problems, especially in medical fields for patients. Start-ups in the catheter-directed thrombolysis industry are making new devices that help to prevent cardiovascular disease. Some of the start-ups are:
Corvus Medical:
Corveus Medical is a US-based start-up company that has developed a new device to prevent heart failure in recent years. The innovative device developed by a company named “neuromodulation device” helps to access heart tissues uniquely and safely.
Moray Medical:
Moray Medical is another US-based start-up that improves leaky heart valves by providing microfluidic robotic methods. The start-up treats its patients safely with cost-effective therapies.
The market is consolidated by the prominent vendors present all around the region in recent years. They are using several marketing tactics to acquire lion’s share and are anticipated to grow the catheter-directed thrombolysis market share during the forecast period.
Some of the marketing methodologies adopted by key players are partnerships, acquisitions, mergers, product launches, and collaborations among others. Global players such as Angio Dynamics, Inc. and Boston Scientific Corporation account for a considerable market size. Several regional-level players are also operating across key growth regions.
Recent Developments in the Catheter-Directed Thrombolysis Market:
| Report Attributes | Details |
|---|---|
| Growth Rate | CAGR of 5.9% from 2023 to 2033 |
| Base Year for Estimation | 2022 |
| Historical Data | 2018 to 2022 |
| Forecast Period | 2023 to 2033 |
| Quantitative Units | Revenue in US$ million and CAGR from 2023 to 2033 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis |
| Segments Covered |
|
| Regions Covered |
|
| Key Countries Profiled |
|
| Key Companies Profiled |
|
| Customization | Available Upon Request |
The market is valued at US$ 454.8 million by 2023.
The market is predicted to reach a size of US$ 808 million by 2033.
United States to hold sizeable share in the market.
A CAGR of 5.9% is predicted for the market by 2033.
From 2018 to 2022, the market registered a CAGR of 4.9%.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Delivery Mode
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Delivery Mode, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Delivery Mode, 2023 to 2033
5.3.1. Direct Delivery to Blood Clot Catheter-directed Thrombolysis
5.3.2. by Positioning Medical Device at Clot Site
5.4. Y-o-Y Growth Trend Analysis By Delivery Mode, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Delivery Mode, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Indication
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By Indication, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Indication, 2023 to 2033
6.3.1. Pulmonary Embolism (PE)
6.3.2. Deep Vein Thrombosis (DVT)
6.3.3. Strokes
6.3.4. Other Indications
6.4. Y-o-Y Growth Trend Analysis By Indication, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By Indication, 2023 to 2033
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) Analysis By End User , 2018 to 2022
7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User , 2023 to 2033
7.3.1. Hospitals
7.3.2. Surgical Centers
7.3.3. Radiology Clinics
7.4. Y-o-Y Growth Trend Analysis By End User , 2018 to 2022
7.5. Absolute $ Opportunity Analysis By End User , 2023 to 2033
8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022
8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033
8.3.1. North America
8.3.2. Latin America
8.3.3. Western Europe
8.3.4. Eastern Europe
8.3.5. South Asia and Pacific
8.3.6. East Asia
8.3.7. Middle East and Africa
8.4. Market Attractiveness Analysis By Region
9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. USA.
9.2.1.2. Canada
9.2.2. By Delivery Mode
9.2.3. By Indication
9.2.4. By End User
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Delivery Mode
9.3.3. By Indication
9.3.4. By End User
9.4. Key Takeaways
10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Rest of Latin America
10.2.2. By Delivery Mode
10.2.3. By Indication
10.2.4. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Delivery Mode
10.3.3. By Indication
10.3.4. By End User
10.4. Key Takeaways
11. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. United Kingdom.
11.2.1.3. France
11.2.1.4. Spain
11.2.1.5. Italy
11.2.1.6. Rest of Western Europe
11.2.2. By Delivery Mode
11.2.3. By Indication
11.2.4. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Delivery Mode
11.3.3. By Indication
11.3.4. By End User
11.4. Key Takeaways
12. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. Poland
12.2.1.2. Russia
12.2.1.3. Czech Republic
12.2.1.4. Romania
12.2.1.5. Rest of Eastern Europe
12.2.2. By Delivery Mode
12.2.3. By Indication
12.2.4. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Delivery Mode
12.3.3. By Indication
12.3.4. By End User
12.4. Key Takeaways
13. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. India
13.2.1.2. Bangladesh
13.2.1.3. Australia
13.2.1.4. New Zealand
13.2.1.5. Rest of South Asia and Pacific
13.2.2. By Delivery Mode
13.2.3. By Indication
13.2.4. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Delivery Mode
13.3.3. By Indication
13.3.4. By End User
13.4. Key Takeaways
14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
14.2.1. By Country
14.2.1.1. China
14.2.1.2. Japan
14.2.1.3. South Korea
14.2.2. By Delivery Mode
14.2.3. By Indication
14.2.4. By End User
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Delivery Mode
14.3.3. By Indication
14.3.4. By End User
14.4. Key Takeaways
15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
15.2.1. By Country
15.2.1.1. GCC Countries
15.2.1.2. South Africa
15.2.1.3. Israel
15.2.1.4. Rest of MEA
15.2.2. By Delivery Mode
15.2.3. By Indication
15.2.4. By End User
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Delivery Mode
15.3.3. By Indication
15.3.4. By End User
15.4. Key Takeaways
16. Key Countries Market Analysis
16.1. USA.
16.1.1. Pricing Analysis
16.1.2. Market Share Analysis, 2022
16.1.2.1. By Delivery Mode
16.1.2.2. By Indication
16.1.2.3. By End User
16.2. Canada
16.2.1. Pricing Analysis
16.2.2. Market Share Analysis, 2022
16.2.2.1. By Delivery Mode
16.2.2.2. By Indication
16.2.2.3. By End User
16.3. Brazil
16.3.1. Pricing Analysis
16.3.2. Market Share Analysis, 2022
16.3.2.1. By Delivery Mode
16.3.2.2. By Indication
16.3.2.3. By End User
16.4. Mexico
16.4.1. Pricing Analysis
16.4.2. Market Share Analysis, 2022
16.4.2.1. By Delivery Mode
16.4.2.2. By Indication
16.4.2.3. By End User
16.5. Germany
16.5.1. Pricing Analysis
16.5.2. Market Share Analysis, 2022
16.5.2.1. By Delivery Mode
16.5.2.2. By Indication
16.5.2.3. By End User
16.6. United Kingdom.
16.6.1. Pricing Analysis
16.6.2. Market Share Analysis, 2022
16.6.2.1. By Delivery Mode
16.6.2.2. By Indication
16.6.2.3. By End User
16.7. France
16.7.1. Pricing Analysis
16.7.2. Market Share Analysis, 2022
16.7.2.1. By Delivery Mode
16.7.2.2. By Indication
16.7.2.3. By End User
16.8. Spain
16.8.1. Pricing Analysis
16.8.2. Market Share Analysis, 2022
16.8.2.1. By Delivery Mode
16.8.2.2. By Indication
16.8.2.3. By End User
16.9. Italy
16.9.1. Pricing Analysis
16.9.2. Market Share Analysis, 2022
16.9.2.1. By Delivery Mode
16.9.2.2. By Indication
16.9.2.3. By End User
16.10. Poland
16.10.1. Pricing Analysis
16.10.2. Market Share Analysis, 2022
16.10.2.1. By Delivery Mode
16.10.2.2. By Indication
16.10.2.3. By End User
16.11. Russia
16.11.1. Pricing Analysis
16.11.2. Market Share Analysis, 2022
16.11.2.1. By Delivery Mode
16.11.2.2. By Indication
16.11.2.3. By End User
16.12. Czech Republic
16.12.1. Pricing Analysis
16.12.2. Market Share Analysis, 2022
16.12.2.1. By Delivery Mode
16.12.2.2. By Indication
16.12.2.3. By End User
16.13. Romania
16.13.1. Pricing Analysis
16.13.2. Market Share Analysis, 2022
16.13.2.1. By Delivery Mode
16.13.2.2. By Indication
16.13.2.3. By End User
16.14. India
16.14.1. Pricing Analysis
16.14.2. Market Share Analysis, 2022
16.14.2.1. By Delivery Mode
16.14.2.2. By Indication
16.14.2.3. By End User
16.15. Bangladesh
16.15.1. Pricing Analysis
16.15.2. Market Share Analysis, 2022
16.15.2.1. By Delivery Mode
16.15.2.2. By Indication
16.15.2.3. By End User
16.16. Australia
16.16.1. Pricing Analysis
16.16.2. Market Share Analysis, 2022
16.16.2.1. By Delivery Mode
16.16.2.2. By Indication
16.16.2.3. By End User
16.17. New Zealand
16.17.1. Pricing Analysis
16.17.2. Market Share Analysis, 2022
16.17.2.1. By Delivery Mode
16.17.2.2. By Indication
16.17.2.3. By End User
16.18. China
16.18.1. Pricing Analysis
16.18.2. Market Share Analysis, 2022
16.18.2.1. By Delivery Mode
16.18.2.2. By Indication
16.18.2.3. By End User
16.19. Japan
16.19.1. Pricing Analysis
16.19.2. Market Share Analysis, 2022
16.19.2.1. By Delivery Mode
16.19.2.2. By Indication
16.19.2.3. By End User
16.20. South Korea
16.20.1. Pricing Analysis
16.20.2. Market Share Analysis, 2022
16.20.2.1. By Delivery Mode
16.20.2.2. By Indication
16.20.2.3. By End User
16.21. GCC Countries
16.21.1. Pricing Analysis
16.21.2. Market Share Analysis, 2022
16.21.2.1. By Delivery Mode
16.21.2.2. By Indication
16.21.2.3. By End User
16.22. South Africa
16.22.1. Pricing Analysis
16.22.2. Market Share Analysis, 2022
16.22.2.1. By Delivery Mode
16.22.2.2. By Indication
16.22.2.3. By End User
16.23. Israel
16.23.1. Pricing Analysis
16.23.2. Market Share Analysis, 2022
16.23.2.1. By Delivery Mode
16.23.2.2. By Indication
16.23.2.3. By End User
17. Market Structure Analysis
17.1. Competition Dashboard
17.2. Competition Benchmarking
17.3. Market Share Analysis of Top Players
17.3.1. By Regional
17.3.2. By Delivery Mode
17.3.3. By Indication
17.3.4. By End User
18. Competition Analysis
18.1. Competition Deep Dive
18.1.1. AngioDynamics Inc.
18.1.1.1. Overview
18.1.1.2. Product Portfolio
18.1.1.3. Profitability by Market Segments
18.1.1.4. Sales Footprint
18.1.1.5. Strategy Overview
18.1.1.5.1. Marketing Strategy
18.1.2. Boston Scientific Corporation
18.1.2.1. Overview
18.1.2.2. Product Portfolio
18.1.2.3. Profitability by Market Segments
18.1.2.4. Sales Footprint
18.1.2.5. Strategy Overview
18.1.2.5.1. Marketing Strategy
18.1.3. iVascular SLU
18.1.3.1. Overview
18.1.3.2. Product Portfolio
18.1.3.3. Profitability by Market Segments
18.1.3.4. Sales Footprint
18.1.3.5. Strategy Overview
18.1.3.5.1. Marketing Strategy
18.1.4. Straub Medical AG
18.1.4.1. Overview
18.1.4.2. Product Portfolio
18.1.4.3. Profitability by Market Segments
18.1.4.4. Sales Footprint
18.1.4.5. Strategy Overview
18.1.4.5.1. Marketing Strategy
18.1.5. Thrombolex Inc.
18.1.5.1. Overview
18.1.5.2. Product Portfolio
18.1.5.3. Profitability by Market Segments
18.1.5.4. Sales Footprint
18.1.5.5. Strategy Overview
18.1.5.5.1. Marketing Strategy
18.1.6. Teleflex Incorporated
18.1.6.1. Overview
18.1.6.2. Product Portfolio
18.1.6.3. Profitability by Market Segments
18.1.6.4. Sales Footprint
18.1.6.5. Strategy Overview
18.1.6.5.1. Marketing Strategy
18.1.7. Straub Medical AG
18.1.7.1. Overview
18.1.7.2. Product Portfolio
18.1.7.3. Profitability by Market Segments
18.1.7.4. Sales Footprint
18.1.7.5. Strategy Overview
18.1.7.5.1. Marketing Strategy
18.1.8. Penumbra, Inc.
18.1.8.1. Overview
18.1.8.2. Product Portfolio
18.1.8.3. Profitability by Market Segments
18.1.8.4. Sales Footprint
18.1.8.5. Strategy Overview
18.1.8.5.1. Marketing Strategy
18.1.9. Medtronic Plc
18.1.9.1. Overview
18.1.9.2. Product Portfolio
18.1.9.3. Profitability by Market Segments
18.1.9.4. Sales Footprint
18.1.9.5. Strategy Overview
18.1.9.5.1. Marketing Strategy
18.1.10. Inari Medical, Inc.
18.1.10.1. Overview
18.1.10.2. Product Portfolio
18.1.10.3. Profitability by Market Segments
18.1.10.4. Sales Footprint
18.1.10.5. Strategy Overview
18.1.10.5.1. Marketing Strategy
19. Assumptions & Acronyms Used
20. Research Methodology
Explore Healthcare Insights
View Reports
Catheter-Directed Thrombolysis Market
